72.11.Z - Research and experimental development on biotechnology
21.10 - Manufacture of basic pharmaceutical substances
46.75 - Wholesale of chemical products
61.20.Z - Wireless telecommunications activities, excluding satellite telecommunications activities
62.01.Z - Computer programming activities
71.12 - Engineering activities and related technical consultancy
71.20 - Technical testing and analysis
72.19 - Other research and experimental development on natural sciences and engineering
77.40 - Leasing of intellectual property and similar products, except copyrighted works
95.12.Z - Repair and maintenance of (tele)communication equipment
2019 | 2020 | 2021 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Total assets | 242,6 | 235,6 | 182,1 | -22,7 |
Total operating revenue | 14,5 | 181,8 | 170,6 | -6,1 |
Gross profit / loss | 2,9 | -7,9 | 106,6 | 1456,5 |
Liabilities and provisions | 153 | 4 | 0 | -100 |
Equity | 89,6 | 231,7 | 182,1 | -21,4 |
Net profit / loss | 2,9 | -7,9 | 100,4 | 1377,2 |
Current assets | 161,7 | 159,8 | 111,3 | -30,4 |
% | % | % | p.p. | |
Return on equity (ROE) | 3,2 | -3,4 | 55,1 | 58,5 |
Return on sales (ROS) | 19,7 | -4,3 | 58,9 | 63,2 |
Gross profit margin | 19,7 | -4,3 | 62,5 | 66,8 |
Equity ratio | 36,9 | 98,3 | 100 | 1,7 |
Opinions regarding services, products, and company activities are not verified. This means that ING Services for Business S.A., as the provider of the Aleo platform, does not ensure that the published opinions come from consumers who have used the product or availed of the company's services. However, we do strive to ensure that opinions do not violate universally applicable laws.